
Sunil Pai Dayananda
About Sunil Pai Dayananda
Data last updated:
Sunil Pai Dayananda has 13 years in corporate governance. Holds Managing Director and Director roles. Currently with 1 company, including Futura Therapeutics Private Limited and Renos Pharma Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Renos Pharma Private Limited at ₹3.39 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 May 2016 | 2016 | ₹3.39 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 02 Nov 2012 | 2012 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunil Pai Dayananda
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunil Pai Dayananda
Sunil Pai Dayananda has 13 years in corporate governance. Holds Managing Director and Director roles. Currently with 1 company, including Futura Therapeutics Private Limited and Renos Pharma Private Limited. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Renos Pharma Private Limited at ₹3.39 Cr (FY 2024).
Sunil Pai Dayananda is associated with 1 company as Managing Director and Director, including Renos Pharma Private Limited (₹3.39 Cr).
Sunil Pai Dayananda has expertise in General Business.
Sunil Pai Dayananda has 13 years in corporate governance.
By reported revenue, the largest current company of Sunil Pai Dayananda is Renos Pharma Private Limited, with revenue of ₹3.39 Cr (FY 2024).
Sunil Pai Dayananda currently holds positions at 1 company: Renos Pharma Private Limited (₹3.39 Cr).